The value of case series in adverse drug reaction assessment

Q4 Medicine

Adverse Drug Reaction Bulletin Pub Date : 2011-10-01 DOI:10.1097/FAD.0b013e32834d17dc

A. Pariente, C. N. A. Chakra, M. Pinet, Lenhangmbong Nkeng, N. Moore, Y. Moride

引用次数: 0

Abstract

Summary Case studies are recognized as important tools for monitoring drug safety, particularly after the drug is licensed and being used widely. Recently, criteria have been formulated to ensure that published case reports and case series are robust, but these are not always met in practice.

查看原文本刊更多论文

病例序列在药物不良反应评估中的价值

案例研究被认为是监测药物安全性的重要工具，特别是在药物获得许可并被广泛使用之后。最近，已经制定了标准，以确保已发表的病例报告和病例系列是可靠的，但在实践中并不总是符合这些标准。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Adverse Drug Reaction Bulletin Medicine-Pharmacology (medical)

CiteScore

0.70

自引率

0.00%

发文量

期刊介绍： For over 40 years, Adverse Drug Reaction Bulletin has provided comprehensive coverage in the field of adverse drug reactions. Each issue contains an invited article on a topic of current interest, dealing with specific conditions from drug-induced lung disorders to drug-induced sexual dysfunction, or types of drugs from lipid-lowering agents to poisons antidotes. This bimonthly journal"s articles are timely, succinct and fully referenced